Hemangini Shah, DO
Radiation Oncology · Manahawkin, NJNPI 1336162015
Payments from drug & device makers
Across 84 payments — averaging $37.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$370
- Bioprotect Medical, Inc.$314
- Johnson & Johnson$228
- Abbott$160
- AstraZeneca$153
- Coherus Oncology, Inc.$138
- plus $2K from 29 others
What the payments were for
- Food & beverage$3,111100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 9 | $370 |
| Bioprotect Medical, Inc. | 8 | $314 |
| Johnson & Johnson | 17 | $228 |
| Abbott | 1 | $160 |
| AstraZeneca | 4 | $153 |
| Coherus Oncology, Inc. | 2 | $138 |
| Regeneron Healthcare Solutions, Inc. | 2 | $132 |
| Silk Road Medical, Inc. | 1 | $122 |
| BD | 1 | $121 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $117 |
| Verastem, Inc. | 1 | $114 |
| Heron Therapeutics, Inc. | 1 | $114 |
| AbbVie | 1 | $109 |
| Boehringer Ingelheim | 1 | $100 |
| Beigene USA, Inc. | 1 | $98 |
| Zap Surgical Systems, Inc. | 1 | $96 |
| Seagen Inc. | 2 | $78 |
| Incyte Corporation | 4 | $58 |
| Bristol Myers Squibb | 2 | $52 |
| Pfizer | 3 | $50 |
| Sanofi | 3 | $48 |
| Exelixis Inc. | 1 | $44 |
| Blue Earth Diagnostics | 2 | $37 |
| Telix Pharmaceuticals | 2 | $36 |
| Boston Scientific | 1 | $31 |
| Eisai Inc. | 2 | $28 |
| Teleflex LLC | 1 | $27 |
| Lilly USA, LLC | 2 | $24 |
| Progenics Pharmaceuticals, Inc. | 1 | $24 |
| Novocure Inc. | 1 | $22 |
| Novartis | 1 | $15 |
| AMAG Pharmaceuticals, Inc. | 1 | $14 |
| Bayer | 1 | $12 |
| Astellas Pharma US Inc | 1 | $11 |
| EUSA Pharma (US) LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BIOPROTECT BALLOON IMPLANT SYSTEM$200
- FREESTYLE LIBRE 3$160
- Udenyca$125
- ENROUTE Transcarotid Stent$122
- ENROUTE Transcarotid Neuroprotection System$122
- Phasix Mesh$121
- IMBRUVICA$117
- CINVANTI$114
- Copiktra$114
- Kyprolis$114
- IMFINZI$114
- LIBTAYO$114
- EMRELIS$109
- JARDIANCE$100
How this compares
$3,111 in reported general payments places this provider in the 80th percentile of 132 radiation oncology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 115 | $2,032 |
| Oxybutynin Chloride | 11 | $167 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Manahawkin
- David D'ambrosioManahawkin$1K
- Atif KhanNew Brunswick$4.7M
- Salma JabbourNew Brunswick$2.9M
- Glen GejermanHackensack$631K
- Michael GreenbergCherry Hill$335K
- Yao YuMiddletown$303K
- Marc RudoltzWest Orange$166K
- Edward SoffenMonroe Twp$165K
- Brett LewisHackensack$122K
- Bruce HafftyNew Brunswick$81K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.